Skip to main content

AI Summary of Article 271 Determination of the exposure value

This summary addresses the determination of exposure values for certain derivative instruments as outlined in the applicable regulatory framework. Institutions are mandated to evaluate these exposure values in accordance with the specified Chapter, ensuring compliance with prevailing standards.

Moreover, institutions have the discretion to assess the exposure values for various transactions—such as repurchase agreements, securities lending, and margin lending—per the guidelines of this Chapter, rather than relying on the provisions in Chapter 4. This flexibility aims to streamline reporting and enhance regulatory alignment.

Version status: Applicable | Document consolidation status: Updated to reflect all known changes
Version date: 1 January 2014 - onwards
Version 4 of 4

Article 271 Determination of the exposure value

1. An institution shall determine the exposure value of derivative instruments listed in Annex II in accordance with this Chapter.

2. An institution may determine the exposure value of repurchase transactions, securities or commodities lending or borrowing transactions, long settlement transactions and margin lending transactions in accordance with this Chapter instead of making use of Chapter 4.